Brushing and Flossing for the New Year

December 20, 2012

The end of the year is fast approaching. This is usually a time for reflection over the year that is ending, and planning for the different ways we will approach the New Year. Something you should consider for 2013 is to make a commitment to brushing and flossing.

The New Year is a good time to start on new healthy habits, so why not start this year off right? Also, don’t forget to come see Dr. Henkel twice a year for your regular checkup!

It is important to make sure you brush your teeth twice a day to help remove all the plaque and debris from your teeth. Brush at morning and night, and make sure you brush for two full minutes each time. This is critical to ensure that all plaque is removed.

Flossing is really important because it helps remove the plaque that’s stuck between your teeth and cannot be removed by brushing alone. If allowed to remain, this plaque could result in tooth decay. Make sure you floss your teeth at least once a day.

If you need some brushing or flossing tips, don’t hesitate to call us here at Horsham Dental Elements. We’re here to help with all your dental health needs!

Call our Horsham or Philadelphia office today to schedule your appointment with Horsham Dental ElementsDr. Henkel provides quality and experienced care to patients from Montgomery, Philadelphia, Horsham, Bucks County, and beyond.

Comfortable Periodontal Therapy with Laser Dentistry

October 16, 2012

Periodontal disease—which you know better as gum disease—is a common oral health condition. It’s so common, in fact, that as much as 80% of the population may have some form of it. Symptoms of gum disease include:

  • Bleeding gums
  • Red or tender gums
  • Frequent bad breath

But a lack of these symptoms doesn’t mean you’re gum disease-free. In some cases there are no symptoms, meaning there are patients who have gum disease without realizing it.

All of which makes regular visit to Horsham Dental Elements very important. During a regular visit to our Horsham or Philadelphia office, Dr. Henkel can thoroughly assess your oral health to check for signs of gum disease and a range of other common conditions.

If we find signs of gum disease, Dr. Henkel can provide effective periodontal therapy with laser dentistry. Periodontal therapy with a soft-tissue laser is more comfortable than traditional therapy with a scalpel, and is more efficient too. What’s more, therapy with a laser doesn’t require stitches and comes with a much shorter recovery time.

Why Is Treating Periodontal Disease Important?

Not treating gum disease has serious implications for your oral and overall health. On the oral health side, gum disease is the leading cause of adult tooth loss. On overall health side, medical studies have linked gum disease with a wide variety of serious health conditions, including heart disease, diabetes, and stroke, among others.

Schedule Your Next Visit Today!

How long has it been since your last checkup with Dr. Henkel? Call our Horsham or Philadelphia office today if you need to schedule a visit. With our comprehensive services, we can meet a wide variety of important general, cosmetic, and restorative dentistry needs.

Boost Your Smile’s Appearance with Cosmetic Dentistry

October 2, 2012

When you feel embarrassed about your smile, you’re less likely to be the fun, outgoing person you want to be. But with a smile makeover using one of Dr. Henkel’s cosmetic dentistry services, you can enjoy a brighter, straighter-looking smile that will improve your self-esteem.

Our cosmetic dentistry services include:

Cosmetic Bonding

Has a dental injury, decay, or teeth grinding caused your teeth to become broken or worn? With single-visit cosmetic bonding, Dr. Henkel can reshape your smile using a putty-like resin that can be custom-shaded to match your existing tooth color, resulting in a new smile that looks beautiful and natural.

Teeth Whitening

Teeth whitening is one of the most effective and most popular cosmetic dentistry services available. And at Dr. Henkel’s Horsham and Philadelphia dental offices, we offer both in-office and take-home teeth whitening options. Both are an effective way of achieving stunning, professional results.

Porcelain Veneers

As another of today’s most popular and effective cosmetic dentistry services, porcelain veneers can help you make your teeth appear straighter and whiter, combining the benefits of cosmetic bonding and teeth whitening. What’s more, treatment with porcelain veneers can typically be completed in just two to three visits.

Want To Know More?

Do you want to learn more about how any one of these great services can help you improve your smile? Call Horsham Dental Elements to reserve a consultation appointment with Dr. Henkel. During your appointment, Dr. Henkel can get to know you and your smile and would be happy to recommend the treatment plan that will help you the most.

Call us today! We have offices in Horsham and Philadelphia.

Rejuvenate Your Smile with Restorative Dentistry from Horsham Dental Elements

August 14, 2012

A beautiful smile is important, but so is a functional smile. That’s why Horsham Dental Elements offers a wide range of restorative dentistry services. Using our popular and effective restorative dentistry services, Dr. Gary Henkel can help patients from Horsham, Philadelphia, and beyond enjoy renewed confidence, improved functionality, and a better quality of life.

Our restorative dentistry services include:

But which of these is right for you?

Unfortunately, a blog post can’t tell you that—only a consultation appointment at our Horsham or Philadelphia office can. Which is why we’d like to go ahead and invite anyone who needs restorative dental care to call one of our offices for an appointment. During a simple consultation visit Dr. Henkel can take a close look at your smile and find out what your needs are. We can also tell you which of our restorative dentistry services are right for you and explain how each one works.

Are you ready to transform your smile? Give us a call today. You can also click on the links above to find out more about our services.

Dr. Henkel serves patients from Philadelphia, Horsham, and surrounding areas with excellent general, restorative, and cosmetic dentistry. We look forward to helping you!

Quality Dental Care for the Entire Family

July 3, 2012

At Horsham Dental Elements, what you’ll find is an experienced and knowledgeable team eager to help your entire family enjoy optimal oral health. And with two locations, we can extend that care to patients from Horsham, Montgomery, Philadelphia, Bucks County, and beyond.

Meeting Your Family’s Needs to Create Beautiful Smiles

Part of how Dr. Gary Henkel and our team are helping families every day is through meeting basic needs. That means treating decay and cases of gum disease at their earliest stages, before they’ve developed into cases that would require extensive restorative care.

General dentistry is about more than just meeting basic needs, though. It’s also about prevention. At Horsham Dental Elements we recommend that all patients—no matter what age—come to see us twice a year for a regular cleaning and checkup. Our goal through these regular visits is to help you maintain your oral health so that a more serious problem never develops. If it does, though, we can catch it quickly and begin working on a treatment plan with a regular exam and cleaning.

Regular visits and cleanings also give Dr. Henkel and our team a chance to educate our patients about good homecare. As effective as professional cleanings are, they’re only effective when they’re supported by great brushing and flossing at home. While you’re in our Horsham or Philadelphia office we’d be happy to talk to you about how you can take better care of your smile at home.

Is It Time for Your Next Appointment?

If it’s time for you to schedule your next appointment for yourself or your child, don’t hesitate to call Horsham Dental Elements today. Dr. Henkel serves patients from Montgomery, Philadelphia, Bucks County and beyond.

 

BISPHOSPHONATE COATED IMPLANTS?????

March 14, 2012

Filed under: Uncategorized — admin @ 10:32 am

Strange as it may sound, implants with bisphosphonate coatings have entered human trials, with reported stronger connections of bone to the implant. here is a summary of the research:

 

New method for stronger dental implants

Millions of people have bad teeth replaced with implants. Often following the procedure, they are unable to chew food for up to six months, until the implant has become fixated in the bone. Now, for the first time, a drug coating that has been tested on humans allows titanium screws to adhere to the bone better and faster. The Linköping researchers behind the method report that the results are good.
En käke med två olika implantat
The study, led by Per Aspenberg, professor of orthopaedic surgery at Linköping University, is published in the journal Bone and was highlighted in this week’s edition of the British Medical Journal (BMJ).
The implants are screwed into the jawboneand provide purchase for artificial teeth. Using current technology, it may take four to six months before the bone surrounding the screw has healed and is strong enough so the patient can begin to benefit from surgery.
The coating, developed at Linköping University in Sweden, consists of a nanometre-thin layer of protein that attaches to the metal surface. Attached to the protein is a drug belonging to the bisphosphonates, usually used to treat osteoporosis. Several animal studies have shown that this method allows the bone surrounding the implant to rapidly become denser and stronger.
Now, for the first time, this method has been tested on humans. 16 patients each received two implants; one normal and a similar surface-treated implant as described above. Neither the patient nor the dental surgeon knew which was which. After six months it was noted that for 15 of the 16 patients the treated screw was markedly much better established. Already after two months X-ray images showed positive changes adjacent to the treated screws. No complications occurred.
“It is the first time ever anyone has succeeded in reinforcing the bone around an implant with localised medication”, says Per Aspenberg, professor of orthopaedics, who devised the method of using bisphosphonates in this way.
Pentti Tengvall, professor of biomaterials, developed the method of adhering the drug to the screw and the study was conducted by Jahan Abtahi, specialist MD and PhD, supported by Per Aspenberg. Addbio AB is a Linköping based company now working on commercializing the surface treatment for different types of implants in bone.
Article:A bisphosphonate-coating improves the fixation of metal implants in human bone. A randomized trial of dental implants by Jahan Abtahi, Pentti Tengvall and Per Aspenberg. The journal ‘Bone’ (in press), published online 10 February 2012.
Contact:Per Aspenberg +46 733 866 468
Related Links
osteoklasterna anfaller
Osteoclasts are giant bone-eating cells and when they attack, the bone is broken up and the implant loosens. The new coating is resistant to attack.
Drawing: Per Aspenberg

 

Åke Hjelm 2012-02-29

 

Harvesting autogenous bone made quick and easy

March 5, 2012

Filed under: Uncategorized — admin @ 11:50 am

Recently, Neo Biotech in Korea has developed a special trephine bur with a sleeve they call the ACM or Auto Chip Maker.  This unique device fits in the standard osteotomy latch type handpiece, is run between 300 to 500 rpms, and will penetrate 4mm deep to a safety stop, each penetration yielding about one cc of autogenous particulate.  I have posted an eight minute video showing it being used to repair an ailing implant on you tube, which can be seen here:

http://www.youtube.com/watch?v=GqICDDfXM-A&list;=UUU49GWbwWG0uiwmbhm1xnyw&index;=1&feature;=plcp

Periapical pathology may not be a contraindication for immediate implant placement

February 1, 2012

Filed under: Uncategorized — admin @ 10:39 am
Background: Many patients requiring implant therapy present with hopeless teeth exhibiting periapical pathology. The
advisability of implant placement in such situations has not
been conclusively determined.
Methods: Sixty-four patients underwent therapy in their
maxillary incisor region. Treatment consisted of immediate
implant placement in a site demonstrating periapical pathology, and immediate implant placement in a ‘‘pristine’’ site,
either during the same visit or during separate visits. The implants placed in the sites demonstrating periapical pathology
were followed in function for £117 months, with a mean time in
function of 64 months. The implants placed in pristine sites
were followed in function for £120 months, with a mean time
in function of 62 months.
Results: Two implants in the central incisor positions of one
patient demonstrated 2 mm of buccal recession after 46
months in function. These implants were deemed esthetic failures, despite the absence of in?ammation and continued clinical implant immobility, yielding cumulative survival rates of
98.1 and 98.2 for implants placed in sites with periapical pathology and implants placed in sites without periapical pathology, respectively, according to published criteria.
Conclusions: Implants immediately placed in sites demonstrating periapical pathology yielded results comparable to
those immediately placed in pristine sites. The difference in
survival rates was not statistically signi?cant. J Periodontol
2012;83:182-186.
KEY WORDS
Dental implants; dental materials; pathology, oral; peri

PERI IMPLANTITIS MORE PREVALENT IN SMOKERS AND THOSE WITH PERIO DISEASE

November 3, 2011

Filed under: Uncategorized — admin @ 10:22 am

A recent publication out of sweden showed a positive correlation between peri implantitis and previous perio disease and smoking.  the abstract is post here:

Swed Dent J. 2010;34(2):53-61.

Peri-implantitis in a specialist clinic of periodontology. Clinicalfeatures and risk indicators.

Source

Department of Periodontology at Kista-Skanstull, Folktandvården i StockholmsIän AB, Stockholm, Sweden.

Abstract

Implant therapy has become a widely recognizedtreatment alternative for replacing missing teeth. Several long term follow-upstudies have shown that the survival rate is high. However, complications mayappear and risk indcators associated with early and late failures have beenidentified. The purpose of the present retrospective clinical study was todescribe some clinical features of patients with clinical signs ofperi-implantitis and to identify risk indicators of peri-implantitis in apopulation at a specialist clinic of Periodontology. In total,the materialconsisted of 377 implants in 111 patients with thediagnosis peri-implantitis. The mean age at the examination was found to be56.3 years (range 22-83) for females and 64.1 years (range 27-85) for males.The mean number of remaining teeth was found to be 10.5 (S.D. 8.89) and themean number of implants was 5.85 (S.D. 3.42). Fora majority of the subjects, more than 50% of the remaining teeth had a marginalbone loss of more than 1/3 of the root length. Forty-sex percent of thepatients visited regularly dental hygienists for supportive treatment. Thepercentage of implants with peri-implantitis wassignificantly increased for smokers compared to non-smokers (p = 0.04). In thegroup of non-smokers, 64% of the implants had thediagnosis peri-implantitis, while the corresponding relative frequency forsmokers was 78%. A majority of the individuals had a Plaque index and Bleedingon probing index >50%. The median of the follow-up time after implantplacement was 7.4 years and the observation period was not significantlycorrelated to the degree of bone loss around the implants.Among the subjects with a mean bone loss >6 mm at implantswith peri-implantitis, more than 70% had a mean marginal bone loss > 1/3 ofthe root length of the remaining teeth. A positive and significant correlationwas found between the degree of marginal bone loss in remaining teeth and thedegree of bone loss around implants withperi-implantitis. In conclusion, the results of the present study indicate thatsmoking as well as previous history of periodontitis are associated withperi-implantitis and may represent risk factors for this disease



MIX ACETOMINOPHEN AND IBUPROFEN FOR BEST RESULTS

November 1, 2011

Filed under: Uncategorized — admin @ 3:10 pm

 

Dr. Richard L. Wynn is Professor of Pharmacology at the University of Maryland Dental School. He holds a BS degree in Pharmacy and a PhD degree in Pharmacology. He chaired the Department of Pharmacology at the University of Maryland Dental School from 1980 to 1995. He is the lead author of the Drug Information Handbook for Dentistry, a co-author on many other dental drug publications, an author of over 300 refereed scientific journal articles, a consultant to the Academy of General Dentistry, a featured columnist, and a featured speaker presenting more than 500 courses in continuing dental education. One of his primary interests continues to be keeping dental professionals informed of all aspects of drug use in dental practice.

Over-the-Counter Ibuprofen and Acetaminophen in Combination are Superior to Each Agent Alone in Treating Postoperative Pain

The first two reports (Derry, et al and Toms, et al) describe the efficacy of single doses of ibuprofen and single doses of acetaminophen for postoperative pain, compared to placebo in well-controlled trials. The third report (Mehlisch, et al) describes the analgesic benefits of the combination of the two agents (compared with each drug alone), again in well-controlled trials. These studies provide further evidence-based information for the rational use of over-the-counter pain relievers for postoperative dental pain.
Study #1 Assessing the efficacy of single dose over-the-counter ibuprofen
Derry C, Derry S, Moore RA, et al, “Single Dose Oral Ibuprofen for Acute Postoperative Pain in Adults,” Cochrane Database Syst Rev, 2009, July 8, (3) CD001548.
The objective of this study was to assess the analgesic efficacy of ibuprofen in single oral doses for moderate and severe postoperative pain in adults. The method was to search the Cochrane Library, CENTRAL, MEDLINE, EMBASE, and the Oxford Pain Relief Database for studies to May, 2009. Selection of studies considered for review was based on randomized, double-blind, placebo-controlled trials of single-dose orally administered ibuprofen in adults with moderate to severe acute postoperative pain. Pain relief or pain intensity data were extracted and converted to outcomes of numbers of participants with at least 50% pain relief over 4 to 6 hours, from which relative risk and number-needed-to-treat-to-benefit (NNT) were calculated. The number of participants using rescue medication over specified time periods, and the time to rescue medication, were sought as additional measures of efficacy. Finally, information on adverse events and withdrawals was collected.
Results of the Derry, et al, study
The studies reviewed totaled 72 and included 9,186 participants, in which ibuprofen was compared to placebo. The majority of the studies used ibuprofen at 200 mg and 400 mg doses.
For at least 50% pain relief compared with placebo, the number-needed-to-treat-to-benefit for ibuprofen 200 mg (2,690 participants) was 2.7 (2.5 to 3.0) and for ibuprofen 400 mg (6,475 participants) it was 2.6 (2.4 to 2.6).
The proportion with at least 50% pain relief was 46% with 200 mg ibuprofen and 54% with 400 mg ibuprofen. Remedication within 6 hours was less frequent with higher doses, with 48% remedicating with 200 mg and 42% remedicating with 400 mg. The median time to remedication was 4.7 hours for 200 mg and 5.4 hours for 400 mg.
The studies using dental impaction pain models and soluble ibuprofen salts (liquid gel capsule formulations) produced better efficacy estimates. Adverse events were uncommon and no different from placebo.
The authors concluded a substantial amount of high quality evidence demonstrated that over-the-counter ibuprofen is an effective pain reliever in treating postoperative pain.
Study #2 Assessing the efficacy of single dose over-the-counter acetaminophen
Toms L, McQuay HJ, Derry S, et al, “Single Dose Oral Paracetamol (Acetaminophen) for Postoperative Pain in Adults,” Cochrane Database Syst Rev, 2008, Oct 8, (4) CD004602.
The objective of this study was to assess the efficacy of single dose oral acetaminophen for the treatment of acute postoperative pain. The method was to search the Cochrane Library, MEDLINE, EMBASE, the Oxford Pain Relief Database, and reference lists of articles to update data from an existing version of the review. Selection of studies considered for review was based on randomized, double-blind, placebo-controlled trials of acetaminophen for acute postoperative pain in adults.
Area under the “pain relief versus time” curve was used to derive the proportion of participants with acetaminophen or placebo experiencing at least 50% pain relief over 4 to 6 hours, using validated equations. Number-needed-to-treat-to-benefit was calculated. The proportion of participants using rescue analgesia over a specified time period and time to use were sought as measures of duration of analgesia. Information on adverse events and withdrawals was also collected.
Results of the Toms, et al, study
Fifty-one studies with 5,762 participants were included; of those who took acetaminophen or placebo, 3,277 participants were treated with a single oral dose of acetaminophen and 2,425 with placebo. About half of the participants treated with acetaminophen at standard doses achieved at least 50% pain relief over 4 to 6 hours compared with about 20% treated with placebo.
Number-needed-to-treat-to-benefit for at least 50% pain relief over 4 to 6 hours following a single 500 mg dose of acetaminophen was 3.5 (2.7 to 4.8); following a single 600 to 650 mg dose it was 4.6 (3.9 to5.5); following a single dose of 975 to 1000 mg it was 3.6 ( 3.4 to 4.0).
About half the participants taking acetaminophen needed additional analgesia over 4 to 6 hours compared with about 70% with placebo.
Five people would need to be treated with 1000 mg acetaminophen, the most commonly used dose, to prevent one needing rescue medication over 4 to 6 hours, who would have needed it with placebo.
Reported adverse events were mild and transient, and occurred at similar rates with 1000 mg acetaminophen and placebo. No serious adverse events were reported.
The authors concluded that a single dose of acetaminophen provided effective analgesia for about half of the patients with acute postoperative pain for a period of about 4 hours and is associated with few, mainly mild, adverse events.
Study #3 Assessing the efficacy of the combination of over-the-counter ibuprofen and acetaminophen
Mehlisch DR, Aspley S, Daniels SE, et al, “Comparison of the Analgesic Efficacy of Concurrent Ibuprofen and Paracetamol With Ibuprofen or Paracetamol Alone in the Management of Moderate to Severe Acute Postoperative Dental Pain in Adolescents and Adults: A Randomized, Double-blind, Placebo-controlled, Parallel-group, Single-dose, Two-center, Modified Factorial Study,” Clin Ther, 2010, 32:882-95.
This study was done to test the hypothesis that combination analgesics may offer improved analgesic efficacy, particularly for moderate to severe pain. The authors evaluated the analgesic benefits of concurrent ibuprofen and paracetamol (acetaminophen), compared with each drug used alone, in the management of acute postoperative dental pain.
Methods
The study enrolled healthy patients, ages 16 to 40 years, undergoing surgical removal of 3 to 4 impacted molars. The protocol was a randomized, double-blind, placebo-controlled, parallel-group, single-dose, two center study. Patients were randomly assigned to ibuprofen 400 mg/acetaminophen 1000 mg combination, ibuprofen 200 mg/acetaminophen 500 mg combination, ibuprofen 400 mg alone, acetaminophen 1000 mg alone, or placebo when the postoperative pain reached moderate to severe intensity.
The primary endpoint of efficacy was the sum of pain relief and pain intensity differences from 0 to 8 hours. Secondary endpoints included total pain relief, sum of pain intensity differences, and sum of pain intensity differences on the visual analog scale at various time endpoints. Other analgesic measures included peak effect, onset and duration of effect, and patients’ overall assessment of treatment. The tolerability of study medicines was also assessed in terms of frequency and nature of adverse events.
Results of the Mehlisch, et al, study
A total of 234 patients were randomly assigned to treatment and included in the intent-to-treat population.
Results for the primary endpoint
For the sum of pain relief and pain intensity differences, the group receiving the combination of ibuprofen 400 mg/acetaminophen 1000 mg had significantly better mean scores compared with ibuprofen 400 mg alone, acetaminophen 1000 mg alone and the combination of ibuprofen 200 mg/acetaminophen 500 mg.
For the sum of pain relief and pain intensity differences, the group receiving the combination of ibuprofen 200 mg/acetaminophen 500 mg had significantly better mean scores compared with acetaminophen 1000 mg alone, but not compared to ibuprofen 400 mg alone.
Results for secondary endpoints
Ibuprofen 400 mg/acetaminophen 1000 mg was associated with significantly better scores than was single agent therapy for total pain relief, sum of pain intensity differences, and sum of pain intensity differences on the visual analog scale at all time intervals, and for sum of pain relief and pain intensity differences from 4 to 6 hours.
A breakdown of the Mehlisch, et al, data showed the following:
Time to the first confirmed perceptible pain relief for each treatment was:
Ibuprofen 400 mg/acetaminophen 1000 mg: 23 minutes
Ibuprofen 200 mg/acetaminophen 500 mg: 22 minutes
Ibuprofen 400 mg: 49 minutes
Acetaminophen 1000 mg: 25 minutes
Placebo: 98 minutes
Time to the first meaningful pain relief for each treatment was:
Ibuprofen 400 mg/acetaminophen 1000 mg: 94 minutes
Ibuprofen 200 mg/acetaminophen 500 mg: 74 minutes
Ibuprofen 400 mg: 124 minutes
Acetaminophen 1000 mg: 141 minutes
Placebo: 133 minutes
Time to pain half gone for each treatment was:
Ibuprofen 400 mg/acetaminophen 1000 mg: 70 minutes
Ibuprofen 200 mg/acetaminophen 500 mg: 86 minutes
Ibuprofen 400 mg: 114 minutes
Acetaminophen 1000 mg: 135 minutes
Placebo: 229 minutes
There were significant differences in favor of all active treatments versus placebo for all efficacy endpoints. Adverse events were similar across treatments, with the most frequent being nausea [26.1% (61/234)], vomiting [18.8% (44/234)], headache [10.3% (24/234)], and dizziness [8.1% (19/234)].
The authors concluded that concurrent ibuprofen and acetaminophen appeared to provide significantly better analgesic efficacy compared with either drug alone for management of acute postoperative dental pain.


Drug information is constantly changing. Promote medication safety in your practice with Lexicomp Online for Dentistry.

« Newer PostsOlder Posts »